Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer

British Journal of Surgery

Volumn 99, Issue 5, 2012, Pages 699-705

  Segelman, J ^a,c   Granath, F ^b   Holm, T ^a   MacHado, M ^c   Mahteme, H ^d   Martling, A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c ERSTA HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COLON TUMOR; EPIDEMIOLOGY; FEMALE; HUMAN; MALE; METASTASIS; MIDDLE AGED; MULTIPLE CANCER; PERITONEUM TUMOR; PROGNOSIS; RECTUM TUMOR; SECOND CANCER; SWEDEN;

ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, SECOND PRIMARY; PERITONEAL NEOPLASMS; PROGNOSIS; RECTAL NEOPLASMS; SWEDEN; YOUNG ADULT;

EID: 84859590873     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.8679     Document Type: Article

References (24)

1. Sugarbaker PH, Jablonski KA,. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg 1995; 221: 124-132.
2. Franko J, Ibrahim Z, Gusani NJ, Holtzman MP, Bartlett DL, Zeh HJ III,. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis. Cancer 2010; 116: 3756-3762.
3. Elias D, Gilly F, Boutitie F, Quenet F, Bereder JM, Mansvelt B, et al., Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 2010; 28: 63-68.
4. Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, et al., Randomized trial of cryoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003; 21: 3737-3743.
5. Mahteme H, Hansson J, Berglund A, Påhlman L, Glimelius B, Nygren B, et al., Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study. Br J Cancer 2004; 90: 403-407.
6. Elias D, Goéré D, Di Pietrantonio D, Boige V, Malka D, Kohneh-Shahri N, et al., Results of systematic second-look surgery in patients at high risk of developing colorectal peritoneal carcinomatosis. Ann Surg 2008; 247: 445-450.
7. Mohamed F, Cecil T, Moran B, Sugarbaker P,. A new standard of care for the management of peritoneal surface malignancy. Curr Oncol 2011; 18: e84-e96.
8. Lefevre JH, Elias DM,. Cytoreductive surgery plus intraperitoneal chemohyperthermia in patients with colorectal cancer at high risk for local-regional recurrence. Cancer J 2009; 15: 200-203.
9. Sugarbaker PH,. Revised guidelines for second-look surgery in patients with colon and rectal cancer. Clin Transl Oncol 2010; 12: 621-628.
10. Ripley RT, Davis JL, Kemp CD, Steinberg SM, Toomey MA, Avital I,. Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases. Trials 2010; 11: 62.
11. ClinicalTrials.gov. Trial Comparing Simple Follow-up to Exploratory Laparotomy Plus 'in Principle' (Hyperthermic Intraperitoneal Chemotherapy) HIPEC in Colorectal Patients (ProphyloCHIP). [accessed 4 October 2011].
12. Dawson LE, Russell AH, Tong D, Wisbeck WM,. Adenocarcinoma of the sigmoid colon: sites of initial dissemination and clinical patterns of recurrence following surgery alone. J Surg Oncol 1983; 22: 95-99.
13. Koppe MJ, Boerman OC, Oyen WJ, Bleichrodt RP,. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg 2006; 243: 212-222.
14. Socialstyrelsen. Swedish Cancer Registry. [accessed 4 October 2011].
15. Segelman J, Singnomklao T, Hellborg H, Martling A,. Differences in multidisciplinary team assessment and treatment between patients with stage IV colon and rectal cancer. Colorectal Dis 2009; 11: 768-774.
16. Sobin LH, Wittekind C, (eds). TNM Classification of Malignant Tumors (6th edn). John Wiley: New York, 2002.
17. Wille-Jorgensen P, Laurberg S, Pahlman L, Carriquiry L, Lundqvist N, Smedh K, et al., An interim analysis of recruitment to the COLOFOL trial. Colorectal Dis 2009; 11: 756-758.
18. Colorectal Cancer: National Clinical Guidelines 2008; [in Swedish; accessed 4 October 2011].
19. Jayne DG, Fook S, Loi C, Seow-Choen F,. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 2002; 89: 1545-1550.
20. Socialstyrelsen. Dödsorsaker 2005 - Summary. [accessed 4 October 2011].
21. Willett C, Tepper JE, Cohen A, Orlow E, Welch C,. Obstructive and perforative colonic carcinoma: patterns of failure. J Clin Oncol 1985; 3: 379-384.
22. Verwaal VJ,. Long-term results of cytoreduction and HIPEC followed by systemic chemotherapy. Cancer J 2009; 15: 212-215.
23. Mitchard JR, Love SB, Baxter KJ, Shepherd NA,. How important is peritoneal involvement in rectal cancer? A prospective study of 331 cases. Histopathology 2010; 57: 671-679.
24. Petersen VC, Baxter KJ, Love SB, Shepherd NA,. Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer. Gut 2002; 51: 65-69.